Status:
NOT_YET_RECRUITING
Effects of Oral Tranexamic Acid on Short Term Postoperative Outcomes Following Total Shoulder Arthroplasty
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Shoulder Arthroplasty
Eligibility:
All Genders
18-79 years
Phase:
PHASE3
Brief Summary
The purpose of this clinical trial is to evaluate the short-term clinical outcomes of patients undergoing total shoulder arthroplasty who receive an extended postoperative course of oral tranexamic ac...
Eligibility Criteria
Inclusion
- Skeletally mature patients (ages 18-79) undergoing primary total shoulder arthroplasty
Exclusion
- Patients with Cancer, venous thromboembolism, stroke, heart disease, pregnant or nursing, allergic to TXA, current tobacco use, anticoagulants other than aspirin.
Key Trial Info
Start Date :
December 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06902714
Start Date
December 15 2025
End Date
December 1 2030
Last Update
October 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35205